Dissolved and financials
CVR: 38300067
Not available
Net result: DKK -55,703
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 19 May 2020
CVR · view overview
1 employee
Annual report 2019 · average
Director role ended: Janne Refnov
CVR · 19/05/2020
View the full event history
Asperix ApS was a Danish company of the type Anpartsselskab based in Rødovre, founded in 2017. The company has been dissolved on 19 May 2020. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2019 annual report, the company had an average of 1 employee. In 2019, the company reported a net result of DKK -55,703. Equity in the 2019 report amounted to DKK 127,550.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/07/2018 – 30/06/2019 | - | -56 t. | 136 t. | 128 t. | 1 |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. Asperix ApS is registered in the Danish CVR register with the status Dissolved and ceased on 19 May 2020.
The CVR number of Asperix ApS is 38300067.
Asperix ApS had an average of 1 employee in the 2019 financial year according to the annual report.
Asperix ApS was founded on 2 January 2017.
Asperix ApS was registered under the industry Ikke-finansielle holdingselskaber (industry code 642020).
Asperix ApS was located at Amorinvej 25, 2610 Rødovre.
As of May 19, 2020, Janne Refnov has stepped down as director of Asperix ApS.
Asperix ApS was dissolved on May 19, 2020.
Asperix ApS has published its annual report for 2019. The net result was DKK -55,703.
Asperix ApS has published its interim report for the period January 2, 2017 to June 30, 2018.
As of January 2, 2017, Janne Refnov is registered as director of Asperix ApS.
Asperix ApS was founded on January 2, 2017.
